The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. Herein, we report the final results from the same trial, including the efficacy of a booster dose.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/efficacy-and-safety-rtssas01-malaria-vaccine-or-without-booster-dose-infants-and
[2] http://admin.indiaenvironmentportal.org.in/category/journal/lancet
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-borne-diseases
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-control